Skip to main content

Table 2 The clinical course of the patients.

From: Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease

Patient

Time from start of IVIG to onset, hrs

Treatment

Time to recovery

1 y male

33

15 mg/kg mPSL

1 day

6 y female

40

15 mg/kg mPSL

2 days

7 y female

25

None

2 days

10 y female

31

None

1 day

  1. IVIG = intravenous immunoglobulin; mPSL = methylprednisolone.
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096